Women's Health Ultrasound

This summer's breast imaging research spanned digital breast tomosynthesis (DBT) efficiency gains, AI models that flag cancer risk years before diagnosis, a cautionary study on automation bias, and advances in ultrasound, MRI, and contrast-enhanced mammography (CEM). Here is a look back at the most well-viewed breast imaging content of the summer.

Catch up on the top AI-related news and research in radiology over the past month.

New research revealed that risk-stratified MRI surveillance in patients with cirrhosis led to over a 10 percent increase in early detection and over a 44 percent decrease in surveillance exams in comparison to reported results with semiannual ultrasound monitoring.

Catch up on the top radiology content of the past week.

Catch up on the latest episodes of our Breast Imaging in Focus series with Manisha Bahl, MD, MPH, FSBI, discussing research on a variety of topics including breast arterial calcification on mammograms, automated breast ultrasound, AI and GLP-1 receptor agonists.

In a recently published review of the BI-RADS v2025 manual, leading breast radiologists offered pertinent insights on key changes for reporting of mammogram, breast ultrasound and breast MRI interpretation and assessment.

Catch up on the top AI-related news and research in radiology over the past month.

A model combining MRI and ultrasound findings yielded a 93 percent AUC for predicting microvascular invasion in hepatocellular carcinoma.

The updated Sonosite iLOOK ultrasound reportedly offers a variety of features designed to streamline the use of point-of-care ultrasound for vascular access procedures.

In light of the recent death of Sen. Lindsey Graham from aortic dissection, we highlight pertinent diagnostic principles and key imaging findings for the timely detection of aortic dissection, a topic that Alan Braverman, MD, FACC, discussed in an interview with Diagnostic Imaging.

The Alturion ultrasound device reportedly combines portability, AI-enhanced capabilities and a user-friendly interface to facilitate streamlined workflows.

The Star RF Electrode and VIVA RF Electrode are reportedly the first devices to garner a specific cleared indication for benign thyroid nodule ablation.

While use of an AI software demonstrated significantly higher accuracy in evaluating BI-RADS 2 presentations and no significant difference with radiologists in BI-RADS 4 assessments of breast ultrasound in a sub-analysis, researchers noted the exclusion of galactoceles, fluid collections and skin lesions that are commonly found in pregnant and lactating women.

Catch up on a variety of new FDA clearances in radiology from the past week.

Reportedly trained on thousands of cardiac ultrasound images, the Ejection Fraction (EF) AI tool provides automated measurement of left ventricular ejection fraction (LVEF) in seconds.

The AI-powered Elevate Plus reportedly facilitates standardization of routine ultrasound, improves scan time and bolsters image quality.

Catch up on the most-well viewed radiology content in May 2026.

Catch up on the top radiology content of the past week.

The updated Break Wave lithotripsy device for kidney stone treatment reportedly has ultrasound therapy probes with a 31 percent smaller footprint.

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Recent research demonstrated that non-physician operators with brief training on the Accuro XV ultrasound system had a greater than 90 percent rate for obtaining diagnostically adequate images.

Catch up on the top AI-related news and research in radiology over the past month.

In a recent interview, Manisha Bahl, MD, discussed new breast ultrasound research findings that showed 16 percent higher specificity for breast cancer with adjunctive AI in comparison to unassisted interpretation.

Facilitating real-time visualization of deep vessel structures and high-resolution surface detail within a single workflow, the hybrid intravascular ultrasound (IVUS)/optical coherence tomography (OCT) platform will be launched in the second quarter of 2026.

Approximately 15 percent of women with abnormal screening mammography results and adverse social determinants of health (SDOH) had follow-up diagnostic mammography or breast ultrasound within 30 days, according to multinational research presented at the Society of Breast Imaging symposium.